Reply to M Bishop

Reply to M. Dhanushkodi

In a letter to the editor in response to our recent article in Journal of Global Oncology titled “Outcomes of Saudi Arabian PatientsWith Nasopharyngeal Cancer Treated With Primarily Neoadjuvant ChemotherapyFollowedbyConcurrentChemoradiotherapy,” Dhanushkodi raises some interesting points. The Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) demonstrated improved overall survival...

Reply to M. Dhanushkodi

We thankDhanushkodi sincerely for his questions regarding our study, “Cardiovascular Disease Risk Factors:HowRelevant inAfricanMenwithProstate Cancer Receiving Androgen-Deprivation Therapy?” In our facility, the gonadotropin-releasing hormone agonist used is goserelin. The dose administered is 3.6 mg every 28 days subcutaneously until the prostate-specific antigen (PSA) level is 0 ng/mL. Then t...

[Reply to the letter of M. Grignon and F. Jusot].

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers. L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau...

Reply to J M Stanley: fiddling and clarity.

The author responds to John M. Stanley's criticism ("More fiddling with the definition of death?" Journal of Medical Ethics 1987 Mar; 13(1): 21-22) and clarifies the arguments in his own previous article ("Why let people die?" Journal of Medical Ethics 1986 Jun; 12(2): 83-86). Gillett contends that we must decide what ethical stance we should adopt toward the living but nonsentient, devoid of ...

Reply to Christopher M . Jones and Michael Niederweis